PDCD1 and pleural neoplasm: However, the proportion of PD-1+ IL-10R+ T cells does not support distinguishing between malignant and paramalignant effusions, as in 45% (10/22) of the patients with paramalignant effusions, a pleural tumor involvement was confirmed throughout the course of the disease.